2021 ASM results

21 July 2021 Results of Blis Technologies Limited Annual Shareholder Meeting At Blis Technologies Limited's shareholder meeting, held in Dunedin and online today, shareholders were asked to vote on 3 resolutions, which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: o That Mr Geoffrey Plunket be re-elected as a director of the Company. o That Dr Barry Richardson be re-elected as a director of the Company. o That the Directors be authorised to fix the remuneration of the auditors for the ensuing year. Details of the total number of votes cast in person or by a proxy holder are: Resolution For Against Abstain That Mr Geoffrey Plunket be re-elected as a director of the Company. 516,028,191 (99.46%) 2,819,525 (0.54%) 4,598,555 That Dr Barry Richardson be re-elected as a director of the Company. 519,193,466 (99.96%) 200,000 (0.04%) 4,052,805 That the Directors be authorised to fix the remuneration of the auditors for the ensuing year. 519,356,466 (99.99%) 37,000 (0.01%) 4,052,805 Subsequent to the meeting, Tony Offen has stood down as Chairman of the Board after holding the position since August 2017. Mr Offen also advised that he will not be seeking re-election at next year's Annual Shareholder Meeting when he is due to retire by rotation as provided for under the Company's constitution. Mr Geoffrey Plunket has been confirmed as the new Chairman. "On behalf of the Board I would like to thank Tony for his passionate leadership. During his tenure as Chair, the Company has achieved a number of significant milestones. We look forward to his continued involvement on the Board." said Mr Plunket. Ends For further information, please contact: Geoffrey Plunket Chairman +64 21 229 8886 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS(R) products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. Website: www.unconditionalskin.com Instagram: @unconditionalskin #BLISQ24 #USC Facebook: @unconditionalskin End CA:00376002 For:BLT Type:MEETING Time:2021-07-21 13:43:56